These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24656770)

  • 1. Acquired channelopathies as contributors to development and progression of multiple sclerosis.
    Schattling B; Eggert B; Friese MA
    Exp Neurol; 2014 Dec; 262 Pt A():28-36. PubMed ID: 24656770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
    Ellwardt E; Zipp F
    Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages and neurodegeneration.
    Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation.
    Mendez-Huergo SP; Maller SM; Farez MF; Mariño K; Correale J; Rabinovich GA
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):247-55. PubMed ID: 24684768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology.
    Voet S; Prinz M; van Loo G
    Trends Mol Med; 2019 Feb; 25(2):112-123. PubMed ID: 30578090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathology of multiple sclerosis.
    Sobel RA
    Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.
    Ziemssen T
    J Neurol; 2005 Nov; 252 Suppl 5():v38-45. PubMed ID: 16254701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The good and the bad of neuroinflammation in multiple sclerosis.
    Naegele M; Martin R
    Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glial cells in innate immunity and their role in CNS demyelination.
    Sriram S
    J Neuroimmunol; 2011 Oct; 239(1-2):13-20. PubMed ID: 21907419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated CNS damage.
    Kierdorf K; Wang Y; Neumann H
    Results Probl Cell Differ; 2010; 51():173-96. PubMed ID: 19130024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: a battle between destruction and repair.
    McQualter JL; Bernard CC
    J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.